最新の財務諸表(Form-10K)によると、Transmedics Group Incの総資産は$0で、純損失は$0です。
XCRTの主要な財務比率は何ですか?
Transmedics Group Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Xcelerate Incの収益はセグメントまたは地域別にどのように分けられていますか?
現在、Transmedics Group Inc のデータは利用できません。
Xcelerate Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Transmedics Group Incの純損失は$0です。
Xcelerate Incに負債はありますか?
いいえ、Transmedics Group Incの負債は0です。
Xcelerate Incの発行済株式数は何株ですか?
Transmedics Group Incの総発行済株式数は0株です。
主要データ
前終値
$0.0108
始値
$0.009
当日レンジ
$0.009 - $0.0109
52週レンジ
$0.0061 - $0.02
取引高
17.5K
平均取引高
170.6K
配当利回り
--
1株当たり利益(TTM)
--
時価総額
$4.7M
XCRTとは何ですか?
Xcelerate, Inc. is a medical company, which engages in the provision of acquiring intellectual property technology for medical applications. The company is headquartered in Mauldin, South Carolina. The company went IPO on 2004-10-06. The firm is engaged in three separate but related businesses within the medical, health and wellness sectors. The firm is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.